116 related articles for article (PubMed ID: 22930520)
1. Production of human cytochrome P450 2D6 drug metabolites with recombinant microbes--a comparative study.
Geier M; Braun A; Emmerstorfer A; Pichler H; Glieder A
Biotechnol J; 2012 Nov; 7(11):1346-58. PubMed ID: 22930520
[TBL] [Abstract][Full Text] [Related]
2. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris.
Dietrich M; Grundmann L; Kurr K; Valinotto L; Saussele T; Schmid RD; Lange S
Chembiochem; 2005 Nov; 6(11):2014-22. PubMed ID: 16222729
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification, and biochemical characterization of a human cytochrome P450 CYP2D6-NADPH cytochrome P450 reductase fusion protein.
Deeni YY; Paine MJ; Ayrton AD; Clarke SE; Chenery R; Wolf CR
Arch Biochem Biophys; 2001 Dec; 396(1):16-24. PubMed ID: 11716457
[TBL] [Abstract][Full Text] [Related]
4. Screening for cytochrome P450 expression in Pichia pastoris whole cells by P450-carbon monoxide complex determination.
Gudiminchi RK; Geier M; Glieder A; Camattari A
Biotechnol J; 2013 Jan; 8(1):146-52. PubMed ID: 23070983
[TBL] [Abstract][Full Text] [Related]
5. Double site saturation mutagenesis of the human cytochrome P450 2D6 results in regioselective steroid hydroxylation.
Geier M; Braun A; Fladischer P; Stepniak P; Rudroff F; Hametner C; Mihovilovic MD; Glieder A
FEBS J; 2013 Jul; 280(13):3094-108. PubMed ID: 23552177
[TBL] [Abstract][Full Text] [Related]
6. Functional co-expression of CYP2D6 and human NADPH-cytochrome P450 reductase in Escherichia coli.
Pritchard MP; Glancey MJ; Blake JA; Gilham DE; Burchell B; Wolf CR; Friedberg T
Pharmacogenetics; 1998 Feb; 8(1):33-42. PubMed ID: 9511179
[TBL] [Abstract][Full Text] [Related]
7. Bufuralol hydroxylation by cytochrome P450 2D6 and 1A2 enzymes in human liver microsomes.
Yamazaki H; Guo Z; Persmark M; Mimura M; Inoue K; Guengerich FP; Shimada T
Mol Pharmacol; 1994 Sep; 46(3):568-77. PubMed ID: 7935340
[TBL] [Abstract][Full Text] [Related]
8. The effect of dimethyl sulfoxide on the function of cytochrome P450 2D6 in HepG2 cells upon the co-expression with NADPH-cytochrome P450 reductase.
Narimatsu S; Takatsu N; Yamano S; Inoue Y; Hanioka N; Kiryu K; Naito S; Gonzalez FJ; Yamamoto S
Chem Biol Interact; 2006 Jan; 159(1):47-57. PubMed ID: 16214121
[TBL] [Abstract][Full Text] [Related]
9. Heterologous expression of cytochrome P450 2D6 mutants, electron transfer, and catalysis of bufuralol hydroxylation: the role of aspartate 301 in structural integrity.
Hanna IH; Kim MS; Guengerich FP
Arch Biochem Biophys; 2001 Sep; 393(2):255-61. PubMed ID: 11556812
[TBL] [Abstract][Full Text] [Related]
10. Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes.
Braun A; Geier M; Bühler B; Schmid A; Mauersberger S; Glieder A
Microb Cell Fact; 2012 Aug; 11():106. PubMed ID: 22876969
[TBL] [Abstract][Full Text] [Related]
11. Functional high level expression of cytochrome P450 CYP2D6 using baculoviral expression systems.
Paine MJ; Gilham D; Roberts GC; Wolf CR
Arch Biochem Biophys; 1996 Apr; 328(1):143-50. PubMed ID: 8638923
[TBL] [Abstract][Full Text] [Related]
12. Scalable production and application of Pichia pastoris whole cell catalysts expressing human cytochrome P450 2C9.
Garrigós-Martínez J; Weninger A; Montesinos-Seguí JL; Schmid C; Valero F; Rinnofner C; Glieder A; Garcia-Ortega X
Microb Cell Fact; 2021 Apr; 20(1):90. PubMed ID: 33902608
[TBL] [Abstract][Full Text] [Related]
13. Human NADPH-P450 oxidoreductase modulates the level of cytochrome P450 CYP2D6 holoprotein via haem oxygenase-dependent and -independent pathways.
Ding S; Yao D; Deeni YY; Burchell B; Wolf CR; Friedberg T
Biochem J; 2001 Jun; 356(Pt 2):613-9. PubMed ID: 11368792
[TBL] [Abstract][Full Text] [Related]
14. [CYP2D6*1, CYP2D6*10 co-expressed with CYPOR in Bac-to-Bac expression system and activity determination].
Qian MR; Chen J; Liu Y; Yu LS; Chen SQ; Zeng S
Yao Xue Xue Bao; 2011 Feb; 46(2):207-12. PubMed ID: 21542294
[TBL] [Abstract][Full Text] [Related]
15. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
16. Binding of bufuralol, dextromethorphan, and 3,4-methylenedioxymethylamphetamine to wild-type and F120A mutant cytochrome P450 2D6 studied by resonance Raman spectroscopy.
Bonifacio A; Keizers PH; Commandeur JN; Vermeulen NP; Robert B; Gooijer C; van der Zwan G
Biochem Biophys Res Commun; 2006 May; 343(3):772-9. PubMed ID: 16563352
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase.
Locuson CW; Ethell BT; Voice M; Lee D; Feenstra KL
Drug Metab Dispos; 2009 Mar; 37(3):457-61. PubMed ID: 19074522
[TBL] [Abstract][Full Text] [Related]
18. Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli.
Yamazaki H; Nakamura M; Komatsu T; Ohyama K; Hatanaka N; Asahi S; Shimada N; Guengerich FP; Shimada T; Nakajima M; Yokoi T
Protein Expr Purif; 2002 Apr; 24(3):329-37. PubMed ID: 11922748
[TBL] [Abstract][Full Text] [Related]
19. Improved product-per-glucose yields in P450-dependent propane biotransformations using engineered Escherichia coli.
Fasan R; Crook NC; Peters MW; Meinhold P; Buelter T; Landwehr M; Cirino PC; Arnold FH
Biotechnol Bioeng; 2011 Mar; 108(3):500-10. PubMed ID: 21246504
[TBL] [Abstract][Full Text] [Related]
20. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]